PINK1 and proteostasis deficiencies: After establishing a series of classifiers for disease subtypes that had been genetically and chemically induced, we then tested whether the same approach could be used in a real-world scenario, in which a patient’s genetic status (a carrier of an SNCA or PINK1 mutation) would influence their cellular disease subtype (proteinopathy versus mitochondrial).